MTOR and kidney angiomyolipoma: Of the 46 patients with TSC prescribed an mTOR inhibitor, 16 (21%) were prescribed Everolimus, all but one of these for renal angiomyolipoma, with one patient taking the drug for combined renal and lung disease.